Skip to main content
Top
Published in: Endocrine 2/2015

01-03-2015 | Endocrine Methods and Techniques

Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers

Authors: Gulsah Elbuken, Fatih Tanriverdi, Zuleyha Karaca, Mustafa Kula, Selma Gokahmetoglu, Kursad Unluhizarci, Fahrettin Kelestimur

Published in: Endocrine | Issue 2/2015

Login to get access

Abstract

Salivary cortisol (SC) has been increasingly used as a surrogate biomarker of free cortisol (FC) for the assessment of hypothalamo-pituitary-adrenal (HPA) axis, but there are not enough data regarding its use during ACTH stimulation tests. Therefore, we aimed to determine the responses of SC, calculated free cortisol (cFC) and free cortisol index (FCI) to ACTH stimulation tests in healthy adults. Forty-four healthy volunteers (24 men and 20 women) were included in the study. Low-dose (1 µg) and standard-dose (250 µg) ACTH stimulation tests were performed on two consecutive days. Basal and stimulated total cortisol (TC) and cortisol-binding globulin (CBG) levels and SC levels were measured during both doses of ACTH stimulation tests. cFC (by Coolens’ equation) and FCI levels were calculated from simultaneously measured TC and CBG levels. The minimum SC, cFC, FCI levels after low-dose ACTH stimulation test were 0.21, 0.33, 16.06 µg/dL, and after standard-dose ACTH were 0.85, 0.46, 26.11 µg/dL, respectively, in healthy individuals who all had TC responses higher than 20 µg/dL. Peak CBG levels after both doses of ACTH stimulation tests were found to be higher in women than in men. So, by its effect, peak cFC and FCI levels were found to be lower in female than in male group. Neither TC nor SC levels were affected by gender. cFC and FCI levels depend on CBG levels and they are affected by gender. Cut-off levels for SC, cFC, FCI levels after both low- and standard-dose ACTH stimulation are presented. Studies including patients with adrenal insufficiency would be helpful to see the diagnostic value of these suggested cut-off levels.
Literature
1.
go back to reference I.E. Widmer, J.J. Puder, C. Konig, H. Pargger, H.R. Zerkowski, J. Girard, B. Muller, Cortisol response in relation to the severity of stress and illness. J. Clin. Endocrinol. Metab. 90, 4579–4586 (2005)CrossRefPubMed I.E. Widmer, J.J. Puder, C. Konig, H. Pargger, H.R. Zerkowski, J. Girard, B. Muller, Cortisol response in relation to the severity of stress and illness. J. Clin. Endocrinol. Metab. 90, 4579–4586 (2005)CrossRefPubMed
2.
go back to reference F. Tanriverdi, Z. Karaca, K. Unluhizarci, F. Kelestimur, The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10, 13–25 (2007)CrossRefPubMed F. Tanriverdi, Z. Karaca, K. Unluhizarci, F. Kelestimur, The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10, 13–25 (2007)CrossRefPubMed
3.
go back to reference J.F. Dunn, B.C. Nisula, D. Rodbard, Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 58–68 (1981)CrossRefPubMed J.F. Dunn, B.C. Nisula, D. Rodbard, Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53, 58–68 (1981)CrossRefPubMed
4.
go back to reference T.G. Brien, Human corticosteroid binding globulin. Clin. Endocrinol. 14, 193–212 (1981)CrossRef T.G. Brien, Human corticosteroid binding globulin. Clin. Endocrinol. 14, 193–212 (1981)CrossRef
5.
go back to reference A.H. Hamrahian, T.S. Oseni, B.M. Arafah, Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med. 350, 1629–1638 (2004)CrossRefPubMed A.H. Hamrahian, T.S. Oseni, B.M. Arafah, Measurements of serum free cortisol in critically ill patients. N. Engl. J. Med. 350, 1629–1638 (2004)CrossRefPubMed
6.
go back to reference B.M. Arafah, F.J. Nishiyama, H. Tlaygeh, R. Hejal, Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J. Clin. Endocrinol. Metab. 92, 2965–2971 (2007)CrossRefPubMed B.M. Arafah, F.J. Nishiyama, H. Tlaygeh, R. Hejal, Measurement of salivary cortisol concentration in the assessment of adrenal function in critically ill subjects: a surrogate marker of the circulating free cortisol. J. Clin. Endocrinol. Metab. 92, 2965–2971 (2007)CrossRefPubMed
7.
go back to reference P. Poomthavorn, R. Lertbunrian, A. Preutthipan, A. Sriphrapradang, P. Khlairit, P. Mahachoklertwattana, Serum free cortisol index, free cortisol, and total cortisol in critically ill children. Inten. Care Med. 35, 1281–1285 (2009)CrossRef P. Poomthavorn, R. Lertbunrian, A. Preutthipan, A. Sriphrapradang, P. Khlairit, P. Mahachoklertwattana, Serum free cortisol index, free cortisol, and total cortisol in critically ill children. Inten. Care Med. 35, 1281–1285 (2009)CrossRef
8.
go back to reference J. Coolens, L., Van Baelen, H., Heyns, W.: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid Biochem. 26, 197–202 (1987)CrossRefPubMed J. Coolens, L., Van Baelen, H., Heyns, W.: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J. Steroid Biochem. 26, 197–202 (1987)CrossRefPubMed
9.
go back to reference W.S. Gozansky, J.S. Lynn, M.L. Laudenslager, W.M. Kohrt, Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin. Endocrinol. 63, 336–341 (2005)CrossRef W.S. Gozansky, J.S. Lynn, M.L. Laudenslager, W.M. Kohrt, Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity. Clin. Endocrinol. 63, 336–341 (2005)CrossRef
10.
go back to reference Y. Marcus-Perlman, K. Tordjman, Y. Greenman, R. Limor, G. Shenkerman, E. Osher, N. Stern, Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Clin. Endocrinol. 64, 215–218 (2006)CrossRef Y. Marcus-Perlman, K. Tordjman, Y. Greenman, R. Limor, G. Shenkerman, E. Osher, N. Stern, Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test. Clin. Endocrinol. 64, 215–218 (2006)CrossRef
11.
go back to reference M.S. Lo, M.L. Ng, B.S. Azmy, B.A. Khalid, Clinical applications of salivary cortisol measurements. Singapore Med. J. 33, 170–173 (1992)PubMed M.S. Lo, M.L. Ng, B.S. Azmy, B.A. Khalid, Clinical applications of salivary cortisol measurements. Singapore Med. J. 33, 170–173 (1992)PubMed
12.
go back to reference L.N. Contreras, A.L. Arregger, G.G. Persi, N.S. Gonzalez, E.M. Cardoso, A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Clin. Endocrinol. 61, 675–682 (2004)CrossRef L.N. Contreras, A.L. Arregger, G.G. Persi, N.S. Gonzalez, E.M. Cardoso, A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin. Clin. Endocrinol. 61, 675–682 (2004)CrossRef
13.
go back to reference T. Deutschbein, M. Broecker-Preuss, J. Flitsch, A. Jaeger, R. Althoff, M.K. Walz, K. Mann, S. Petersenn, Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur. J. Endocrinol. 166, 613–618 (2012)CrossRefPubMed T. Deutschbein, M. Broecker-Preuss, J. Flitsch, A. Jaeger, R. Althoff, M.K. Walz, K. Mann, S. Petersenn, Salivary cortisol as a diagnostic tool for Cushing’s syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur. J. Endocrinol. 166, 613–618 (2012)CrossRefPubMed
14.
go back to reference K. Simunkova, R. Hampl, M. Hill, J. Doucha, L. Starka, K. Vondra, Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol. Res. 56, 449–453 (2007)PubMed K. Simunkova, R. Hampl, M. Hill, J. Doucha, L. Starka, K. Vondra, Salivary cortisol in low dose (1 microg) ACTH test in healthy women: comparison with serum cortisol. Physiol. Res. 56, 449–453 (2007)PubMed
15.
go back to reference K. Simunkova, L. Starka, M. Hill, L. Kriz, R. Hampl, K. Vondra, Comparison of total and salivary cortisol in a low-dose ACTH (Synacthen) test: influence of three-month oral contraceptives administration to healthy women. Physiol. Res. 57, 193–199 (2008) K. Simunkova, L. Starka, M. Hill, L. Kriz, R. Hampl, K. Vondra, Comparison of total and salivary cortisol in a low-dose ACTH (Synacthen) test: influence of three-month oral contraceptives administration to healthy women. Physiol. Res. 57, 193–199 (2008)
17.
go back to reference Z. Karaca, A. Lale, F. Tanriverdi, M. Kula, K. Unluhizarci, F. Kelestimur, The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary 14, 134–140 (2011)CrossRefPubMed Z. Karaca, A. Lale, F. Tanriverdi, M. Kula, K. Unluhizarci, F. Kelestimur, The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary 14, 134–140 (2011)CrossRefPubMed
18.
go back to reference A. Beishuizen, L.G. Thijs, I. Vermes, Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Inten. Care Med. 27, 1584–1591 (2001)CrossRef A. Beishuizen, L.G. Thijs, I. Vermes, Patterns of corticosteroid-binding globulin and the free cortisol index during septic shock and multitrauma. Inten. Care Med. 27, 1584–1591 (2001)CrossRef
19.
go back to reference E. Topkas, P. Keith, G. Dimeski, J. Cooper-White, C. Punyadeera, Evaluation of saliva collection devices for the analysis of proteins. Clin. Chim. Acta 413, 66–70 (2012)CrossRef E. Topkas, P. Keith, G. Dimeski, J. Cooper-White, C. Punyadeera, Evaluation of saliva collection devices for the analysis of proteins. Clin. Chim. Acta 413, 66–70 (2012)CrossRef
20.
go back to reference C.W. Le Roux, G.A. Chapman, W.M. Kong, W.S. Dhillo, J. Jones, J. Alaghband-Zadeh, Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. J. Clin. Endocrinol. Metab. 88, 2045–2048 (2003)CrossRefPubMed C.W. Le Roux, G.A. Chapman, W.M. Kong, W.S. Dhillo, J. Jones, J. Alaghband-Zadeh, Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. J. Clin. Endocrinol. Metab. 88, 2045–2048 (2003)CrossRefPubMed
21.
go back to reference J.G. Lewis, M.G. Lewis, P. Elder, An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. Clin. Chim. Acta 328, 121–128 (2003)CrossRefPubMed J.G. Lewis, M.G. Lewis, P. Elder, An enzyme-linked immunosorbent assay for corticosteroid-binding globulin using monoclonal and polyclonal antibodies: decline in CBG following synthetic ACTH. Clin. Chim. Acta 328, 121–128 (2003)CrossRefPubMed
22.
go back to reference N.L. Barlow, J. Holme, R.A. Stockley, P.M. Clark, An evaluation of measured and calculated serum free cortisol in a group of patients with known adrenal suppression. Ann. Clin. Biochem. 47, 200–204 (2010)CrossRefPubMed N.L. Barlow, J. Holme, R.A. Stockley, P.M. Clark, An evaluation of measured and calculated serum free cortisol in a group of patients with known adrenal suppression. Ann. Clin. Biochem. 47, 200–204 (2010)CrossRefPubMed
Metadata
Title
Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers
Authors
Gulsah Elbuken
Fatih Tanriverdi
Zuleyha Karaca
Mustafa Kula
Selma Gokahmetoglu
Kursad Unluhizarci
Fahrettin Kelestimur
Publication date
01-03-2015
Publisher
Springer US
Published in
Endocrine / Issue 2/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0378-8

Other articles of this Issue 2/2015

Endocrine 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.